Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 76179
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Aspirin

Ibuprofen

Naproxen

Celecoxib

Others

Market segment by Application, can be divided into

Drug Store

Hospital Pharmacies

Online

Market segment by players, this report covers

Roche (Genentech)

Amgen

B-MS

Merck

Pfizer

Novartis

Eli Lilly and Company

Johnson & Johnson

GSK

Sanofi

Boehringer Ingelheim

Zhejiang Jiuzhou Pharmaceutical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

1.2 Classification of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type

1.2.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2020

1.2.3 Aspirin

1.2.4 Ibuprofen

1.2.5 Naproxen

1.2.6 Celecoxib

1.2.7 Others

1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application

1.3.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Drug Store

1.3.3 Hospital Pharmacies

1.3.4 Online

1.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast

1.5 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast by Region

1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region, (2016-2021)

1.5.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)

1.5.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)

1.5.6 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

1.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

1.6.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Trends Analysis

2 Company Profiles

2.1 Roche (Genentech)

2.1.1 Roche (Genentech) Details

2.1.2 Roche (Genentech) Major Business

2.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.1.4 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Roche (Genentech) Recent Developments and Future Plans

2.2 Amgen

2.2.1 Amgen Details

2.2.2 Amgen Major Business

2.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.2.4 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Amgen Recent Developments and Future Plans

2.3 B-MS

2.3.1 B-MS Details

2.3.2 B-MS Major Business

2.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 B-MS Recent Developments and Future Plans

2.4 Merck

2.4.1 Merck Details

2.4.2 Merck Major Business

2.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.4.4 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.5.4 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.6.4 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Novartis Recent Developments and Future Plans

2.7 Eli Lilly and Company

2.7.1 Eli Lilly and Company Details

2.7.2 Eli Lilly and Company Major Business

2.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.7.4 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Eli Lilly and Company Recent Developments and Future Plans

2.8 Johnson & Johnson

2.8.1 Johnson & Johnson Details

2.8.2 Johnson & Johnson Major Business

2.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.8.4 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Johnson & Johnson Recent Developments and Future Plans

2.9 GSK

2.9.1 GSK Details

2.9.2 GSK Major Business

2.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.9.4 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 GSK Recent Developments and Future Plans

2.10 Sanofi

2.10.1 Sanofi Details

2.10.2 Sanofi Major Business

2.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.10.4 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Sanofi Recent Developments and Future Plans

2.11 Boehringer Ingelheim

2.11.1 Boehringer Ingelheim Details

2.11.2 Boehringer Ingelheim Major Business

2.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.11.4 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Boehringer Ingelheim Recent Developments and Future Plans

2.12 Zhejiang Jiuzhou Pharmaceutical

2.12.1 Zhejiang Jiuzhou Pharmaceutical Details

2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business

2.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

2.12.4 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share

3.2.2 Top 10 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share

3.2.3 Market Competition Trend

3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2016-2021)

4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021)

5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)

6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)

6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)

6.3.2 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)

7.3.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

7.3.3 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

7.3.5 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

7.3.6 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)

8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)

8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region

8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2016-2026)

8.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8.3.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8.3.4 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8.3.5 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

8.3.7 Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)

9.2 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)

9.3 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

9.3.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)

9.3.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

9.3.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2026)

10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2026)

10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2026)

10.3.2 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

10.3.4 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Region (2016-2021)

Table 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2021-2026)

Table 6. Roche (Genentech) Corporate Information, Head Office, and Major Competitors

Table 7. Roche (Genentech) Major Business

Table 8. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 9. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Amgen Corporate Information, Head Office, and Major Competitors

Table 11. Amgen Major Business

Table 12. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 13. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. B-MS Corporate Information, Head Office, and Major Competitors

Table 15. B-MS Major Business

Table 16. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 17. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck Corporate Information, Head Office, and Major Competitors

Table 19. Merck Major Business

Table 20. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 21. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 25. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 29. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 31. Eli Lilly and Company Major Business

Table 32. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 33. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 35. Johnson & Johnson Major Business

Table 36. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 37. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. GSK Corporate Information, Head Office, and Major Competitors

Table 39. GSK Major Business

Table 40. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 41. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Sanofi Corporate Information, Head Office, and Major Competitors

Table 43. Sanofi Major Business

Table 44. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 45. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 47. Boehringer Ingelheim Major Business

Table 48. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 49. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Zhejiang Jiuzhou Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 51. Zhejiang Jiuzhou Pharmaceutical Major Business

Table 52. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions

Table 53. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Players (2019-2021)

Table 55. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2019-2021)

Table 56. Breakdown of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided

Table 58. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Mergers & Acquisitions in the Past Five Years

Table 59. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) New Entrants and Expansion Plans

Table 60. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Type (2016-2021)

Table 61. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2016-2021)

Table 62. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2021-2026)

Table 63. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021)

Table 64. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2021-2026)

Table 65. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Picture

Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2020

Figure 3. Aspirin

Figure 4. Ibuprofen

Figure 5. Naproxen

Figure 6. Celecoxib

Figure 7. Others

Figure 8. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application in 2020

Figure 9. Drug Store Picture

Figure 10. Hospital Pharmacies Picture

Figure 11. Online Picture

Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2016-2026)

Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region in 2020

Figure 16. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

Figure 22. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

Figure 23. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends

Figure 24. Roche (Genentech) Recent Developments and Future Plans

Figure 25. Amgen Recent Developments and Future Plans

Figure 26. B-MS Recent Developments and Future Plans

Figure 27. Merck Recent Developments and Future Plans

Figure 28. Pfizer Recent Developments and Future Plans

Figure 29. Novartis Recent Developments and Future Plans

Figure 30. Eli Lilly and Company Recent Developments and Future Plans

Figure 31. Johnson & Johnson Recent Developments and Future Plans

Figure 32. GSK Recent Developments and Future Plans

Figure 33. Sanofi Recent Developments and Future Plans

Figure 34. Boehringer Ingelheim Recent Developments and Future Plans

Figure 35. Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans

Figure 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2020

Figure 37. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2020

Figure 39. Global Top 10 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type in 2020

Figure 42. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2021-2026)

Figure 43. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application in 2020

Figure 44. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2021-2026)

Figure 45. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)

Figure 46. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)

Figure 47. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)

Figure 48. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)

Figure 52. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)

Figure 53. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)

Figure 54. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2016-2026)

Figure 62. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)

Figure 69. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)

Figure 70. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz